Cyclin D1 expression in podocytes: regulated by mitogens in collaboration with integrin–extracellular matrix interaction through extracellular signal-regulated kinase

Abstract

Cyclin D1 plays significant roles in cell cycle entry and migration. We have documented that both integrin α3 β1 expressions and the number of podocytes were reduced in focal segmental glomerulosclerosis. We wondered whether integrin–extracellular matrix (ECM) interaction was involved in the regulation of cyclin D1 expression, and the possible signaling pathways in mitogen-stimulating podocytes. Cultured podocytes were divided into serum (mitogens/growth factors)-starved and serum-stimulated groups. Reverse transcription polymerase chain reaction was used to detect cyclin D1 mRNA, and Western blot analysis was used to measure protein concentrations of cyclin D1 and extracellular signal-regulated kinase (ERK) activation (p-ERK/ERK). The integrin–ECM interaction was blocked by anti- β1-integrin monoclonal antibody or RGDS (Arg-Gly-Asp-Ser). The MEK inhibitor, U0126, was used to inhibit ERK activation. The results showed that there was little cyclin D1 protein in serum-starved groups, but it was abundant in serum-stimulated groups. Both cyclin D1 mRNA and protein levels were reduced in serum-stimulated podocytes after blocking integrin–ECM interaction. ERK activation in serum-stimulated podocytes was significantly decreased after blocking integrin–ECM interaction. Cyclin D1 mRNA and protein concentrations in serum-stimulated podocytes were reduced after blocking ERK activation by U0126. We demonstrate that integrin–ECM interaction collaborates with mitogens to activate ERK/mitogen-activated protein kinase pathways which are essential for cyclin D1 expression in podocytes.